The Chemical Warfare: Chemotherapy for Gynecological Neoplasms
Surgical excision alone is rarely enough to cure advanced gynecologic cancer; the microscopic clones that have already escaped the pelvis must be hunted down and destroyed with highly toxic, systemic drugs. Chemotherapy for Gynecological Neoplasms: Current Therapy and Novel Approaches is the fiercely pharmacological, brutally objective master text detailing exactly how to execute this chemical assault. This volume provides the exact dosing algorithms and molecular blueprints required to destroy malignant cells without causing lethal bone marrow failure or catastrophic organ toxicity.
Mastering the Platinum Resistance
The core philosophy of this text is overcoming tumor mutation. The authors aggressively detail the mechanics of recurrent disease. It dictates exactly how an oncologist must alter the treatment protocol when a patient’s ovarian cancer stops responding to standard Carboplatin, mathematically defining “platinum-resistant” disease and detailing the exact salvage regimens (like liposomal doxorubicin or topotecan) required to force the tumor back into remission.
Navigating the Targeted Biologics
The book provides a masterclass in modern molecular intervention. It dictates the exact clinical pathways for angiogenesis inhibitors and PARP inhibitors. It rigorously explores the use of Bevacizumab (Avastin) to physically starve tumors by destroying their blood supply, and Olaparib to exploit genetic weaknesses in BRCA-mutated cancers, moving beyond “carpet-bombing” chemotherapy to highly precise, targeted strikes.
Frequently Asked Questions (FAQs)
Does this book teach doctors how to perform radical cancer surgery?
No, it is a strictly specialized *medical oncology, pharmacology, and targeted therapy textbook* focused entirely on the systemic drug treatment of gynecologic cancers.
Who is the primary audience?
It is the absolute, mandatory daily reference for Medical Oncologists, Gynecologic Oncologists, Oncology Pharmacists, and Infusion Nurses.
